Skip to main content
. 2022 Feb 9;13:836231. doi: 10.3389/fgene.2022.836231

TABLE 2.

Identification of unknown variants in patients with suspected FH.

patient ID 5 6 7 8 9 10
age 38 6 40 44 13 6
sex F M M F F F
ethnicity German German German German Turkish Lebanese
TC (mmol/L) 7.62 14.86 7.88 12.67 14.86 20.61
LDL-C (mmol/L) 5.81 13.52 6.46 9.59 13.26 18.69
genetic change c.1916T>A c.1916T>A c.1844A>G c.1844A>G c.653del c.1474G>A c.1729T>C
exon 13 13/12 12 4 10 12
amino acid change p.(Val639Asp) p.(Val639Asp) p.(Glu615Gly) p.(Glu615Gly) p.(Gly218ValfsTer47) p.(Asp492Asn) p.(Trp577Arg)
protein consequence missense variant missense variant missense variant frame shift missense variant missense variant
zygosity (%) heterozygous (46.2) compound heterozygous (49.7/46.6) heterozygous (46.0) heterozygous (48.5) homozygous (95.4) homozygous (86.6)
dbSNP reference rs794728584 rs794728584/– rs137853966 rs373646964 rs879255000
pathogenicity likely pathogenic likely pathogenic/– pathogenic pathogenic pathogenic
SIFT Sim et al. (2012) deleterious deleterious/deleterious deleterious deleterious deleterious
polyphen2 Adzhubei et al. (2010) benign benign/probably damaging probably damaging probably damaging probably damaging
PROVEAN protein Choi and Chan (2015) deleterious deleterious/deleterious deleterious deleterious deleterious
mutation-taster Steinhaus et al. (2021) disease causing disease causing/disease causing disease causing disease causing disease causing disease causing

TC, total cholesterol; LDL-C, low-density lipoprotein cholesterol.